Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications

Adipocyte
Meghan A Piccinin, Zia A Khan

Abstract

Diabetes leads to complications in select organ systems primarily by disrupting the vasculature of the target organs. These complications include both micro- (cardiomyopathy, retinopathy, nephropathy, and neuropathy) and macro-(atherosclerosis) angiopathies. Bone marrow angiopathy is also evident in both experimental models of the disease as well as in human diabetes. In addition to vascular disruption, bone loss and increased marrow adiposity have become hallmarks of the diabetic bone phenotype. Emerging evidence now implicates enhanced marrow adipogenesis and changes to cellular makeup of the marrow in a novel mechanistic link between various secondary complications of diabetes. In this review, we explore the mechanisms of enhanced marrow adipogenesis in diabetes and the link between changes to marrow cellular composition, and disruption and depletion of reparative stem cells.

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D Accili, S I Taylor
Dec 1, 1989·Differentiation; Research in Biological Diversity·J L Rodríguez Fernández, A Ben-Ze'ev
Jul 24, 1986·The New England Journal of Medicine·S M HaffnerJ K Patterson
May 1, 1995·The Journal of Clinical Investigation·G S HotamisligilB M Spiegelman
Aug 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·N ChristeffE A Nunez
Feb 1, 1996·The New England Journal of Medicine·R V ConsidineT L Bauer
Mar 1, 1996·Diabetes Care·D GiuglianoG Paolisso
Jul 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Y KatayamaN Nagata
Dec 1, 1996·Current Opinion in Cell Biology·R P BrunB M Spiegelman
Jul 25, 1997·The Journal of Biological Chemistry·L FajasJ Auwerx
Feb 7, 1998·Genes & Development·K M Cadigan, R Nusse
Oct 27, 1998·Mayo Clinic Proceedings·T O'BrienB R Zimmerman
Jun 4, 1999·Seminars in Cell & Developmental Biology·D A BernlohrV J LiCata
Jul 2, 1999·Diabetes Care·J T TuominenT Rönnemaa
Feb 15, 2000·The Journal of Biological Chemistry·Y AzumaA Kudo
Aug 23, 2000·The Journal of Clinical Investigation·B B Kahn, J S Flier
Oct 12, 2000·Regulatory Peptides·C M SteppanA G Swick
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·S T NadlerA D Attie
Oct 14, 2000·Annual Review of Cell and Developmental Biology·E D Rosen, B M Spiegelman
Jul 20, 2001·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·G Leidig-Bruckner, R Ziegler
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Yoshinori MiyazakiRalph A DeFronzo
Jul 24, 2002·Diabetologia·R WilliamsUNKNOWN CODE-2 Advisory Board
Sep 12, 2002·Trends in Molecular Medicine·Heidi S CampTodd Leff
Nov 7, 2002·Cell·Shu TakedaGerard Karsenty
Mar 21, 2003·Biochemical and Biophysical Research Communications·Takanori NakamuraGozoh Tsujimoto
Apr 30, 2003·Journal of Bone and Mineral Metabolism·Sumiyo WatanabeToshiro Fujita

❮ Previous
Next ❯

Citations

Oct 4, 2016·Frontiers in Endocrinology·Olfa GhaliChristophe Chauveau
Feb 18, 2019·Endocrine Connections·Ann-Kristin PickeMartina Rauner
Jun 4, 2020·International Journal of Molecular Sciences·Maria Cristina VinciGiulio Pompilio
Feb 10, 2017·Calcified Tissue International·Andrea PalermoNicola Napoli
Mar 28, 2017·Therapeutic Advances in Musculoskeletal Disease·Vikram SundararaghavanNabil A Ebraheim
Jun 2, 2018·Current Osteoporosis Reports·Shanmugam MuruganandanChristopher J Sinal
Dec 14, 2018·Journal of Diabetes Research·Selvalakshmi RathinaveluJameela Banu
Jun 23, 2020·Journal of Diabetes Research·C Eller-VainicherL Gennari
Apr 25, 2021·Journal of Neuroimmunology·Kathleen M Hagen, Shalina S Ousman
May 12, 2021·The Journal of Clinical Endocrinology and Metabolism·Vicente F C AndradeCarolina Aguiar Moreira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.